Feasibility of an Adapted Mindfulness Program to Parkinson's Disease

University Hospital, Bordeaux20 enrolled

Overview

The objective of this study is to determine the feasibility (primary objective) and the effects (secondary objectives) of an Mindfulness Based Stress Reduction (MBSR) program adapted specifically for patients with Parkinson's disease.

In Parkinson's disease (PD) the psychological distress (anxiety and depression), is particularly impacting and often resistant to conventional drug treatment explaining the growing interest of patients in non-drug methods, such as mindfulness meditation. The Mindfulness Based Stress Reduction (MBSR) program has been evaluated in Parkinson's disease, showing main effects on anxiety and depression symptoms. These data remain, however, still fragile, particularly in terms of methodological robustness and number of patients involved and variable size of effects. A clinical trial was recently conducted at the Bordeaux University Hospital with 28 patients with Parkinson's disease . Preliminary results suggest that a program tailored specifically to the expectations and needs of patients with Parkinson's disease could, optimize accessibility, acceptability, and patient compliance for this type of approach while preserving clinical efficacy on anxiety and depression.

Study Type

INTERVENTIONAL

Allocation

Purpose

PREVENTION

Masking

NONE

Enrollment

Conditions

Parkinson Disease

Interventions

Mindfulness Based Stress ReductionPROCEDURE

Inspired by the standard Mindfulness Based Stress Reductio program, the study MAdaPARK is a 8 week program with weekly sessions of 2h30 and a full day of practice designed from the analysis of the post-program interviews carried out as part of the M-PARK study,as well as the reflections of the working group specially set up for this purpose. Several areas of adaptation have been identified: shorter mediations, a break time during the sessions, more times for exchanges, a more developed practice in movement, and finally, more important work based on self-esteem and self-compassion.

Eligibility

Sex: ALLMin age: 18 YearsMax age: 79 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patient suffering from Parkinson's disease, * Patient aged over 18 and under 80, * Patient with a Hoehn and Yahr Stage of 1 to 3, * Patient affiliated or beneficiary of the social security system, * Patient having signed a free, informed and written consent Exclusion Criteria: * Patient with severe motor fluctuations (i.e. scoring 4 to at least one of the following items of part IV of the Movement Disorder Society Unified Parkinson Disease Rating Scale: 4.1 and 4.2 for dyskinesias; 4.3, 4.4 and 4.5 for motor fluctuations), * Patient with acute depression not stabilized by treatment or dating from less than 6 months, * Patient with non-stabilized psycho-behavioral disorders (hallucinations, psychoses, impulse control disorders) dating from less than 6 months, * Patient with major cognitive impairment (Montreal Cognitive Assessment ≤24), * Patient who has already participated in a structured mindfulness meditation program * Patient placed under judicial safeguard, guardianship or curator ship, * Pregnant or breastfeeding women.

Locations (1)

Xavier Arnozan Hospital

Pessac, France

Outcomes

Primary Outcomes

Assess MBSR program

The rate of patients who have completed the entire MBSR program "adapted"

Time frame: Month 4

Secondary Outcomes

Attendance rate

Number of days of practice and daily meditation time.

Time frame: Month 3

Program tolerance

Number of side effects and the difficulties

Time frame: month 1 at month 2

Relevance of the adaptations put in place

It will be evaluated from the analysis of feelings and impressions of patients . These different elements will be obtained from the analysis of the semi-directed interviews (qualitative analysis).

Time frame: month 3

Beck Depression Inventory

Assessment depressive symptoms, minimum value 0 and maximum value 36

Time frame: Day 0 and month 3

Parkinson Anxiety Scale (PAS)

Assessment anxiety symptoms,minimum value 0 and maximum value 48

Time frame: Day 0 and month 3

Parkinson's Disease Sleep Scale

Assessment sleep, minimum value 0 and maximum value 60

Time frame: Day 0 and month 3

Parkinson Disease Questionnaire

Assessment quality of life, minimum value 0 and maximum value 156

Time frame: Day 0 and month 3

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.